Misoprostol (Cytotec)

ISSN 0256-5004 (Print)

AIMS Journal Vol 13 No 3

IMPORTANT DRUG WARNING CONCERNING UNAPPROVED USE OF INTRAVAGINAL OR ORAL MISOPROSTOL IN PREGNANT WOMEN FOR INDUCTION OR LABOR OR ABORTION

August 23, 2000
Re: Cytotec (misoprostol)

Dear Health Care Practitioner:

The purpose of this letter is to remind you that Cytotec administration by any route is contraindicated in women who are pregnant because it can cause abortion. Cytotec is not approved for the induction of labor or abortion.

Cytotec is indicated for the prevention of NSAID (nonsteroidal anti- inflammatory drugs, including aspirin) - induced gastric ulcers in patients at high risk of complications from gastric ulcer, eg the elderly and patients with concomitant debilitating disease, as well as patients at high risk of developing gastric ulceration, such as patients with a history of ulcer.

The uterotonic effect of cytotec is an inherent property of prostaglandin E1 (PGE1), of which Cytotec is a stable, orally active, synthetic analog. Searle has become aware of some instances where Cytotec, outside of its approved indication, was used as a cervical ripening agent prior to termination of pregnancy, or for induction of labor, in spite of the specific contraindications to its use during pregnancy.

Serious adverse events reported following off-label use of Cytotec in pregnant women include maternal or fetal death; uterine hyperstimulation, rupture or perforation requiring uterine surgical repair, hysterectomy or salpingo-oophorectomy, amniotic fluid embolism, severe vaginal bleeding, retained placenta, shock, fetal bradycardia and pelvic pain.

Searle has not conducted research concerning the use of Cytotec for cervical ripening prior to termination of pregnancy or for induction of labor, nor does Searle intend to study or support these uses. Therefore, Searle is unable to provide risk information for Cytotec when it is used for such purposes. In addition to the known and unknown acute risks to the mother and fetus, the effect of Cytotecon the later growth, development and functional maturation of the child when Cytotec is used for induction of labor or cervical ripening has not been established.

Searle promotes the use of Cytotec only for its approved indication. Please read the enclosed updated complete Prescribing Information for Cytotec.

Further information may be obtained by calling 1-800-323-4204.

Michael Cullen MD
Medical Director, US
Searle

Latest Content

Journal

« »

Obituary of Mary Cronk, 1932-2018

AIMS Journal, 2019, Vol 30, No 4 Mary Cronk’s family announced that Mary had passed away on the morning of 21st December 2018. She was known nationally, and international…

Read more

Book Review: When Survivors Give Bi…

ISBN 978-1-594040221 Complete list of book reviews on the AIMS website AIMS Journal, 2019, Vol 30, No 4 Reviewed for AIMS by Kicki Hansard Published in 2004 ISBN 978-1594…

Read more

Book Review: Traumatic Childbirth b…

Complete list of book reviews on the AIMS website AIMS Journal, 2019, Vol 30, No 4 Reviewed by Mari Greenfield First edition, published 2013 ISBN 978-0415678100 272 pages…

Read more

Events

« »

Women's Rights in Healthcare 2019

Speakers will discuss topics including: Post partum psychosis Maternal birth injury Menopause Transgender rights The health and wellbeing of ethnic minority women Female…

Read more

Trauma in Childbearing Conference

Speakers include: Sheena Byrom Jenny Patterson Laura Wood Shona McCann Geraldine Butcher Mary Ross Davie Michelle Wright Sue Hampson Birth Trauma Scotland Emma Currer Nur…

Read more

LCGB 2019 Conference

Lactation Consultants of Great Britain's 2019 Conference. More details from their Facebook event: https://www.facebook.com/events/1383226171814001/

Read more

Latest Campaigns

« »

AIMS Response to MBRRACE-UK Report…

Download PDF MBRRACE-UK: Saving Lives, Improving Mothers’ Care MBRRACE-UK: Perinatal Mortality Surveillance report for births in 2016 www.npeu.ox.ac.uk/mbrrace-uk/reports…

Read more

Implementing Better Births: Continu…

Download PDF Commissioners and providers across England, guided by their MVPs, are working across the country to implement sustainable Continuity of Carer models of care,…

Read more

Beverley Beech summarises the HIW's…

Focussing on the failings of the LSA in the case of Clare Fisher: The Healthcare Inspectorate Wales’ report (2013) Summarised by Beverley Beech In 2013, Healthcare Inspec…

Read more